ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $56,001,000 | +22.2% | 602,544 | -21.7% | 0.13% | +16.4% |
Q3 2021 | $45,834,000 | -58.1% | 769,673 | -52.0% | 0.11% | -58.3% |
Q2 2021 | $109,449,000 | -22.1% | 1,604,833 | -20.7% | 0.26% | -26.3% |
Q1 2021 | $140,504,000 | -1.1% | 2,024,848 | +9.5% | 0.36% | -4.5% |
Q4 2020 | $142,052,000 | -5.7% | 1,848,914 | -8.2% | 0.38% | -22.0% |
Q3 2020 | $150,611,000 | +65.8% | 2,013,784 | +39.5% | 0.48% | +51.3% |
Q2 2020 | $90,842,000 | +154.3% | 1,443,094 | +69.6% | 0.32% | +101.3% |
Q1 2020 | $35,729,000 | +694.7% | 850,710 | +1009.3% | 0.16% | +953.3% |
Q2 2019 | $4,496,000 | -10.2% | 76,690 | -31.4% | 0.02% | -11.8% |
Q1 2019 | $5,009,000 | +12.5% | 111,729 | -2.2% | 0.02% | +6.2% |
Q4 2018 | $4,452,000 | -13.9% | 114,296 | +1.8% | 0.02% | +14.3% |
Q3 2018 | $5,168,000 | -11.8% | 112,306 | -16.4% | 0.01% | -17.6% |
Q2 2018 | $5,859,000 | +187.5% | 134,374 | +160.5% | 0.02% | +183.3% |
Q1 2018 | $2,038,000 | – | 51,590 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |